Clinical Trial Update: Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dose escalation of reslizumab in patients with severe eosinophilic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• reslizumab (reslizumab)

Snippet

Sponsor: McMaster University | Conditions: Asthma; Eosinophilic | Phase 4 | Status: COMPLETED